{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:52:40Z","timestamp":1785462760829,"version":"3.56.0"},"reference-count":37,"publisher":"Wiley","issue":"22","license":[{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007552","name":"AIM at Melanoma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP170401"],"award-info":[{"award-number":["RP170401"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP160183"],"award-info":[{"award-number":["RP160183"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Elevated serum lactate dehydrogenase (sLDH) is associated with poor clinical outcomes in patients with stage IV metastatic melanoma (MM). It is currently unknown if sLDH elevation correlates with distinct molecular, metabolic, or immune features of melanoma metastases. The identification of such features may identify rational therapeutic strategies for patients with elevated sLDH. Thus, we obtained sLDH levels for melanoma patients with metastases who had undergone molecular and\/or immune profiling. Our analysis of multi\u2010omics data from independent cohorts of melanoma metastases showed that elevated sLDH was not significantly associated with differences in immune cell infiltrate, point mutations, DNA copy number variations, promoter methylation, RNA expression, or protein expression in melanoma metastases. The only significant association observed for elevated sLDH was with the number of metastatic sites of disease. Our data support that sLDH correlates with disease burden, but not specific molecular or immunological phenotypes, in metastatic melanoma.<\/jats:p>","DOI":"10.1002\/cam4.3474","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T12:47:45Z","timestamp":1601902065000},"page":"8650-8661","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3730-9004","authenticated-orcid":false,"given":"Grant M.","family":"Fischer","sequence":"first","affiliation":[{"name":"Departments of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston TX USA"},{"name":"Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando C. L.","family":"Carapeto","sequence":"additional","affiliation":[{"name":"Departments of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron Y.","family":"Joon","sequence":"additional","affiliation":[{"name":"Biostatistics The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Haydu","sequence":"additional","affiliation":[{"name":"Surgical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Chen","sequence":"additional","affiliation":[{"name":"Biostatistics The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuchenchu","family":"Wang","sequence":"additional","affiliation":[{"name":"Biostatistics The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Van Arnam","sequence":"additional","affiliation":[{"name":"Departments of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"McQuade","sequence":"additional","affiliation":[{"name":"Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalida","family":"Wani","sequence":"additional","affiliation":[{"name":"Departments of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Melanoma Institute of Australia The University of Sydney North Sydney  NSW Australia"},{"name":"The University of Sydney Sydney NSW Australia"},{"name":"Royal Prince Alfred Hospital NSW Health Pathology Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Tetzlaff","sequence":"additional","affiliation":[{"name":"Departments of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston TX USA"},{"name":"Pathology\/Lab Medicine The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6395-4499","authenticated-orcid":false,"given":"Alexander J.","family":"Lazar","sequence":"additional","affiliation":[{"name":"Departments of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston TX USA"},{"name":"Pathology\/Lab Medicine The University of Texas MD Anderson Cancer Center Houston TX USA"},{"name":"Genomic Medicine The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein A.","family":"Tawbi","sequence":"additional","affiliation":[{"name":"Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Gershenwald","sequence":"additional","affiliation":[{"name":"Surgical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[{"name":"Melanoma Institute of Australia The University of Sydney North Sydney  NSW Australia"},{"name":"The University of Sydney Sydney NSW Australia"},{"name":"Royal Prince Alfred Hospital NSW Health Pathology Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina V.","family":"Long","sequence":"additional","affiliation":[{"name":"Melanoma Institute of Australia The University of Sydney North Sydney  NSW Australia"},{"name":"The University of Sydney Sydney NSW Australia"},{"name":"Royal North Shore Hospital Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0977-0912","authenticated-orcid":false,"given":"Michael A.","family":"Davies","sequence":"additional","affiliation":[{"name":"Departments of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Houston TX USA"},{"name":"Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA"},{"name":"Systems Biology The University of Texas MD Anderson Cancer Center Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,10,5]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2011.0287"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(96)00133-8"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.3.1103"},{"key":"e_1_2_9_5_1","first-page":"3091","article-title":"Prognostic factors in patients with metastatic malignant melanoma","volume":"72","author":"Sirott MN","year":"1993","journal-title":"A multivariate analysis Cancer"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.6.1891"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21409"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/jez.1401640302"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904059"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2668"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30497-2"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2303"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709684"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0127"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-324-0_43"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1027"},{"key":"e_1_2_9_18_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00259","article-title":"Biological validation of RNA sequencing data from formalin\u2010fixed paraffin\u2010embedded primary melanomas","volume":"2","author":"Kwong LN","year":"2018","journal-title":"JCO Precision Oncology"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13954"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1545"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.044"},{"key":"e_1_2_9_22_1","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data. Nature","volume":"4","author":"Yoshihara K","year":"2013","journal-title":"Communications"},{"key":"e_1_2_9_23_1","article-title":"Estimating the population abundance of tissue\u2010infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht E","year":"2016","journal-title":"Genome Biol"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0283"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.02.003"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1392"},{"key":"e_1_2_9_27_1","article-title":"Tumor cell oxidative metabolism as a barrier to PD\u20101 blockade immunotherapy in melanoma. JCI","volume":"4","author":"Najjar YG","year":"2019","journal-title":"Insight"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.05.033"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3340"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0167-x"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature22079"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.02.024"},{"key":"e_1_2_9_33_1","article-title":"Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities. Clinical","volume":"9","author":"Micevic G","year":"2017","journal-title":"Epigenetics"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0095"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2015.2376"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1968.tb02430.x"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(14)50012-6"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2011.43.2.102"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.3474","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.3474","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.3474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T15:20:33Z","timestamp":1693840833000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.3474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,5]]},"references-count":37,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1002\/cam4.3474"],"URL":"https:\/\/doi.org\/10.1002\/cam4.3474","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,5]]},"assertion":[{"value":"2020-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}